Interleukin 6 promotes an in vitro mineral deposition by stem cells isolated from human exfoliated deciduous teeth
Author(s) -
Nunthawan Nowwarote,
Waleerat Sukarawan,
Kiattipan Kanjana,
Prasit Pavasant,
Benjamin Fournier,
Thanaphum Osatha
Publication year - 2018
Publication title -
royal society open science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.84
H-Index - 51
ISSN - 2054-5703
DOI - 10.1098/rsos.180864
Subject(s) - sox2 , deciduous teeth , stem cell , runx2 , cd90 , dental pulp stem cells , homeobox protein nanog , microbiology and biotechnology , cd44 , mesenchymal stem cell , periodontal ligament stem cells , induced pluripotent stem cell , biology , cell growth , cellular differentiation , chemistry , cell , osteoblast , in vitro , embryonic stem cell , cd34 , alkaline phosphatase , medicine , dentistry , biochemistry , gene , enzyme
Interleukin 6 (IL-6) plays various roles including stem cell regulation. The present study investigated the effect of IL-6 on cell proliferation, colony forming unit ability, stem cell marker expression and differentiation ability in stem cells isolated from human exfoliated deciduous teeth (SHEDs). We reported that the isolated cells from dental pulp tissues for deciduous teeth expressed CD44, CD90 and CD105 but not CD45. These cells were able to differentiate into osteoblasts, adipocytes and neuronal-like cells. IL-6 treatment resulted in the significant increase of NANOG, SOX2 and REX1 mRNA expression. However, IL-6 had no effect on cell proliferation and colony forming unit ability. IL-6 did not alter adipogenic and neurogenic differentiation potency. IL-6 supplementation in osteogenic medium led to a significant increase of mineralization. Furthermore, IL-6 upregulated ALP, ANKH and PIT1 mRNA levels. In conclusion, IL-6 participates in the regulation of pluripotent marker expression and is also involved in mineralization process of SHEDs. Hence, IL-6 could be employed as a supplementary substance in culture medium to maintain stemness and to induce osteogenic induction in SHEDs for future regenerative cell therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom